Literature DB >> 22143249

Vitamin D: roles in renal and cardiovascular protection.

Yan C Li1.   

Abstract

PURPOSE OF REVIEW: Great progress has been made in recent years in understanding the expanding roles of the vitamin D endocrine system beyond calcemic regulation, including pathophysiological actions in the kidney and the cardiovascular system. The purpose of this review is to update the recent advance regarding the effects of vitamin D and its analogs on the renal and cardiovascular system. RECENT
FINDINGS: Vitamin D deficiency is not only widely associated with chronic kidney disease and cardiovascular disease in humans, but may also accelerate the disease progression. Dysregulation of vitamin D metabolism caused by renal insufficiency contributes to the low vitamin D status. Preclinical and clinical studies have demonstrated impressive therapeutic outcome with low-calcemic vitamin D analogs in renal and cardiovascular disease. The mechanism underlying the renal and cardiovascular protection involves regulation of multiple signaling pathways by vitamin D including nuclear factor κB, Wnt/β-catenin and the renin-angiotensin system.
SUMMARY: The renal and cardiovascular protective activity of vitamin D revealed in recent studies has profound clinical implications. Nutritional correction of vitamin D deficiency and treatment with vitamin D analogs could be therapeutic options for renal and cardiovascular problems. New vitamin D analogs with better renal and cardiovascular therapeutic efficacy are highly desired. More randomized trials are needed to address these issues.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22143249      PMCID: PMC3574163          DOI: 10.1097/MNH.0b013e32834de4ee

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  88 in total

Review 1.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

2.  Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice.

Authors:  Chunlei Zhou; Fengxiang Lu; Kejiang Cao; Di Xu; David Goltzman; Dengshun Miao
Journal:  Kidney Int       Date:  2008-04-02       Impact factor: 10.612

3.  Renoprotective role of the vitamin D receptor in diabetic nephropathy.

Authors:  Z Zhang; L Sun; Y Wang; G Ning; A W Minto; J Kong; R J Quigg; Y C Li
Journal:  Kidney Int       Date:  2007-10-10       Impact factor: 10.612

4.  25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study.

Authors:  Edward Giovannucci; Yan Liu; Bruce W Hollis; Eric B Rimm
Journal:  Arch Intern Med       Date:  2008-06-09

5.  Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study.

Authors:  Angela Yee-Moon Wang; Christopher Wai-Kei Lam; John E Sanderson; Mei Wang; Iris Hiu-Shuen Chan; Siu-Fai Lui; Mandy Man-Mei Sea; Jean Woo
Journal:  Am J Clin Nutr       Date:  2008-06       Impact factor: 7.045

6.  Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals.

Authors:  Natalya Bodyak; Juan Carlos Ayus; Steven Achinger; Venkatesha Shivalingappa; Qingen Ke; Yee-Shiuan Chen; Debra L Rigor; Isaac Stillman; Hector Tamez; Paul E Kroeger; Ruth R Wu-Wong; S Ananth Karumanchi; Ravi Thadhani; Peter M Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

7.  Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial.

Authors:  Pooneh Alborzi; Nina A Patel; Carla Peterson; Jennifer E Bills; Dagim M Bekele; Zerihun Bunaye; Robert P Light; Rajiv Agarwal
Journal:  Hypertension       Date:  2008-07-07       Impact factor: 10.190

8.  1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter.

Authors:  Weihua Yuan; Wei Pan; Juan Kong; Wei Zheng; Frances L Szeto; Kari E Wong; Ronald Cohen; Anna Klopot; Zhongyi Zhang; Yan Chun Li
Journal:  J Biol Chem       Date:  2007-08-09       Impact factor: 5.157

9.  Vitamin D deficiency and risk of cardiovascular disease.

Authors:  Thomas J Wang; Michael J Pencina; Sarah L Booth; Paul F Jacques; Erik Ingelsson; Katherine Lanier; Emelia J Benjamin; Ralph B D'Agostino; Myles Wolf; Ramachandran S Vasan
Journal:  Circulation       Date:  2008-01-07       Impact factor: 29.690

10.  1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells.

Authors:  Z Zhang; W Yuan; L Sun; F L Szeto; K E Wong; X Li; J Kong; Y C Li
Journal:  Kidney Int       Date:  2007-05-16       Impact factor: 10.612

View more
  24 in total

1.  Survival Analysis with Electronic Health Record Data: Experiments with Chronic Kidney Disease.

Authors:  Yolanda Hagar; David Albers; Rimma Pivovarov; Herbert Chase; Vanja Dukic; Noémie Elhadad
Journal:  Stat Anal Data Min       Date:  2014-08-19       Impact factor: 1.051

2.  Novel markers of graft outcome in a cohort of kidney transplanted patients: a cohort observational study.

Authors:  C Alfieri; A Regalia; G Moroni; D Cresseri; F Zanoni; M Ikehata; P Simonini; M P Rastaldi; G Tripepi; C Zoccali; C Chatziantoniou; Piergiorgio Messa
Journal:  J Nephrol       Date:  2019-01-10       Impact factor: 3.902

3.  New treatments for CKD--new insights into pathogenesis.

Authors:  Eleanor D Lederer; Jon B Klein
Journal:  J Am Soc Nephrol       Date:  2012-09-13       Impact factor: 10.121

Review 4.  Vitamin D receptor signaling in renal and cardiovascular protection.

Authors:  Yan Chun Li
Journal:  Semin Nephrol       Date:  2013-09       Impact factor: 5.299

5.  Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats.

Authors:  Michael Freundlich; Yan C Li; Yasmir Quiroz; Yanauri Bravo; Wacharee Seeherunvong; Christian Faul; Jose R Weisinger; Bernardo Rodriguez-Iturbe
Journal:  Am J Hypertens       Date:  2013-09-26       Impact factor: 2.689

6.  Oral active vitamin d treatment and mortality in maintenance hemodialysis patients.

Authors:  Shukun Wu; Junru Wang; Fang Wang; Li Wang
Journal:  Cardiorenal Med       Date:  2014-10-22       Impact factor: 2.041

7.  Oral paricalcitol: expanding therapeutic options for pediatric chronic kidney disease patients.

Authors:  Michael Freundlich; Carolyn L Abitbol
Journal:  Pediatr Nephrol       Date:  2017-04-27       Impact factor: 3.714

Review 8.  Clinical therapeutic strategies for early stage of diabetic kidney disease.

Authors:  Munehiro Kitada; Keizo Kanasaki; Daisuke Koya
Journal:  World J Diabetes       Date:  2014-06-15

9.  Vitamin D receptor signaling in podocytes protects against diabetic nephropathy.

Authors:  Youli Wang; Dilip K Deb; Zhongyi Zhang; Tao Sun; Weicheng Liu; Dosuk Yoon; Juan Kong; Yunzi Chen; Anthony Chang; Yan Chun Li
Journal:  J Am Soc Nephrol       Date:  2012-11-02       Impact factor: 10.121

Review 10.  Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies.

Authors:  Steven E Lipshultz; Thomas R Cochran; David A Briston; Stefanie R Brown; Peter J Sambatakos; Tracie L Miller; Adriana A Carrillo; Liat Corcia; Janine E Sanchez; Melissa B Diamond; Michael Freundlich; Danielle Harake; Tamara Gayle; William G Harmon; Paolo G Rusconi; Satinder K Sandhu; James D Wilkinson
Journal:  Future Cardiol       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.